磷酸奥司他韦治疗流行性感冒的临床观察

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate and analyze the clinical efficacy of Oseltamivir Phosphate in the treatment of influenza.Methods A total of 127 patients with influenza treated in our hospital from January to December 2017 were selected as the research subjects.They were divided into the control group(n＝57)and the observation group(n＝70)according to the random number table method.The control group was given conventional anti-virus Chinese medicine and the observation group was given Oseltamivir Phosphate.After treatment,the total effective rate,the remission time of fatigue and nasal congestion,fever abatement time and adverse reactions were compared between the two groups of patients.Results The total effective rate in the observation group(90.0%)was higher than that in the control group(66.7%),and the difference was statistically significant(P＜0.05).The remission time of fatigue([33.6±3.5]h)and nasal congestion ([27.3±3.4]h),and fever abatement time ([10.8±2.2]h)in the observation group were respectively shorter than those in the control group([45.8±3.7],[38.2±4.3],[24.2±3.5]h),and the differences were statistically significant(P＜0.05).There was no statistically significant difference in adverse reactions between the two groups of patients(P＞0.05).Conclusion Oseltamivir Phosphate in the treatment of influenza can effectively relieve fatigue,nasal congestion and other symptoms,and accelerate the fever abatement time.The overall effect is significant,and there are fewer adverse reactions.

Key words： Oseltamivir Phosphate Influenza Clinical efficacy Safety

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Ai-Ping

Cite this article:

ZHU Ai-Ping. Clinical observation of Oseltamivir Phosphate in the treatment of influenza[J]. 中国当代医药, 2018, 25(21): 102-104.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I21/102

[1]	张国明，李铁刚，邬丽娟，等.早期应用奥司他韦治疗流感样病例的疗效观察[J].临床急诊杂志，2014，15（11）：675.
[2]	毛爱华.国产奥司他韦治疗流行性感冒67例的临床观察[J].中华实验和临床感染病杂志（电子版），2013，7（1）：107-108.
[3]	童玖兴.磷酸奥司他韦治疗流感样症状患者疗效观察[J].深圳中西医结合杂志，2015，25（22）：84-85.
[4]	杨立新.磷酸奥司他韦颗粒联合小儿氨酚黄那敏颗粒治疗小儿季节性流感的效果[J].中国医药导报，2016，20（15）：120-123.
[5]	董孝云，张璋，朱宏端，等.磷酸奥司他韦联合炎琥宁对儿童流感病毒感染患儿免疫功能及预后的影响分析[J].中华医院感染学杂志，2017，27（11）：2603-2606.
[6]	周涛.磷酸奥司他韦治疗流行性感冒的临床疗效和安全性[J].中外医学研究，2014，12（28）：142-143.
[7]	储开东.磷酸奥司他韦颗粒联合复方板蓝根治疗流感样患儿疗效观察[J].现代中西医结合杂志，2015，22（32）：3592-3594.
[8]	唐志宏.上呼吸道感染疾病的症状诊断与合理的药物治疗[J].黑龙江医药，2013，26（3）：485-488.
[9]	杨海龙.磷酸奥司他韦治疗流行性感冒临床观察[J].中国民族民间医药，2015，20（8）：49-50.
[10]	孙双璐.磷酸奥司他韦治疗流行性感冒的临床效果观察[J].黑龙江医药，2017，58（6）：1327-1329.
[11]	钟敏，焦健，金毅，等.磷酸奥司他韦治疗流行性感冒的效果研究[J].中国处方药，2016，15（8）：64-65.
[12]	陆晓萍，毛顺峰，林越仙.磷酸奥司他韦联合小儿豉翘清热颗粒治疗甲型流行性感冒疗效观察[J].儿科药学杂志，2015，20（2）：24-26.
[13]	赵敬敬，李玉玲.喜炎平注射液、磷酸奥司他韦颗粒、蓝芩口服液治疗流感样病例的临床效果研究[J].中国医学创新，2017，10（6）：40-43.
[14]	石筱蕾，庄一波，王永清，等.不同剂量奥司他韦治疗流行性感冒疑似患儿的临床疗效比较[J].江苏大学学报（医学版），2015，22（5）：444-446.
[15]	涂波，聂为民，丁鹏鹏，等.磷酸奥司他韦联合板蓝根颗粒治疗甲型H1N1流感疗效观察[J].武警医学，2013，24（6）：465-467.